Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Preliminary Results from a Phase 1b Dose De-Escalation Stage of Abnl-Marro 001: An International MDS/MPN Working Group Study

Blood (2023) 142 (Supplement 1): 1874.

https://doi.org/10.1182/blood-2023-181673

Published: 2023

Journal Articles

MYC Copy Number Aberrancies Predict a Worse Prognosis in Patients with Diffuse Large B-Cell Lymphoma

Andres E. Quesada, MD, Parth Desai, MD, Guilin Tang, MD, Pei Lin, MD, Jason R. Westin, MD, Adam C. Seegmiller, MD PhD, C. Cameron Yin, MD PhD, Wei Wang, MD, Jie Xu, MD, Roberto N. Miranda, MD, Nishitha Reddy, MD MSCI, MBBS, L. Jeffrey Medeiros, MD, Shaoying Li, MD

Blood (2016) 128 (22): 154.

https://doi.org/10.1182/blood.V128.22.154.154

Published: 2016

Journal Articles

Experience with MRD Testing in B- ALL By Flow Cytometry Does Not Prevent Interpretative Discordance

Michael Keeney, ART,FIMLS(D), Brent L. Wood, MD PhD, Benjamin Hedley, PhD, Joseph A. DiGiuseppe, MD PhD, Maryalice Stetler-Stevenson, MD PhD, Elisabeth Paietta, PhD, Gerard Lozanski, MD, Adam C. Seegmiller, MD PhD, Bruce W Greig, BS/ MT(ASCP)CCy, Aaron C. Shaver, MD PhD, Lata Mukundan, PhD, Howard R. Higley, PhD, Caroline C Sigman, PhD, Gary Kelloff, MD, John Milburn Jessup, MD, Michael J Borowitz, MD PhD

Blood (2016) 128 (22): 2907.

https://doi.org/10.1182/blood.V128.22.2907.2907

Published: 2016

Journal Articles

MYC/BCL2 Double Hit Lymphoma: What Really Matters

Annapurna Saksena, MD, Parth Desai, MD, Zhuang Zuo, MD PhD, Jie Xu, MD, Pei Lin, MD, Adam C. Seegmiller, MD PhD, C. Cameron Yin, MDPhD, Guilin Tang, MD, Roberto N. Miranda, MD, Jeffrey L. Jorgensen, MD PhD, Nishitha M Reddy, M.B.B.S., L. Jeffrey Medeiros, Shaoying Li, MD

Blood (2015) 126 (23): 3909.

https://doi.org/10.1182/blood.V126.23.3909.3909

Published: 2015

Journal Articles

Mutational Burden in Acute Myeloid Leukemia Is Largely Age Dependent

Aaron C. Shaver, MD PhD, Adam C. Seegmiller, MD PhD, Stephen A. Strickland, MD, Robert D. Daber, PhD, Sanjay R. Mohan, MD, Paul Brent Ferrell, Jr., MD, Cindy Vnencak-Jones, PhD, David R. Head, MD, Annette S. Kim, MD PhD, Mary M. Zutter, MD, Michael R. Savona, MD

Blood (2015) 126 (23): 2605.

https://doi.org/10.1182/blood.V126.23.2605.2605

Published: 2015

Journal Articles

Evidence-Based, Patient-Specific Guidelines Provide Efficient and Cost-Effective Molecular and Cytogenetic Testing in Hematologic Malignancy

Adam C. Seegmiller, MD, PhD, Annette S. Kim, MD, PhD, Claudio A. Mosse, MD, PhD, Mia A. Levy, MD, PhD, Mary Ann Thompson, MD, PhD, Megan K. Kressin, MD, Madan H. Jagasia, MD, Stephen A. Strickland, MD, MSCI, Nishitha M. Reddy, MD, Kristy J. Sinkfield, Samuel A. Santoro, MD, PhD, Mary M. Zutter, MD

Blood (2011) 118 (21): 2073.

https://doi.org/10.1182/blood.V118.21.2073.2073

Published: 2011

Journal Articles

HIV-Associated Plasmablastic Lymphoma: A Multi-Institutional Study

Michael Furman, MD, Pascual Balsalobre, Brady E Beltran, MD, Michele Bibas, MD, Mark Bower, MD, Weina Chen, MD, PhD, Silvia Montoto, MD, Roberto N Miranda, MD, Nahid M. Nanaji, MD, MPH, Jose-Tomas Navarro, MD, Adam C. Seegmiller, MD, PhD, Julie M Vose, MD, Jorge J Castillo, MD

Blood (2011) 118 (21): 1589.

https://doi.org/10.1182/blood.V118.21.1589.1589

Published: 2011

Journal Articles

Increased Sensitivity of Prothrombin Time Using Recombinant Tissue Thromboplastin Reagents: Implications for Plasma Transfusion.

Adam C. Seegmiller, MD, PhD, Ravindra Sarode, MD

Blood (2005) 106 (11): 4058.

https://doi.org/10.1182/blood.V106.11.4058.4058

Published: 2005

NARROW

Preliminary Results from a Phase 1b Dose De-Escalation Stage of Abnl-Marro 001: An International MDS/MPN Working Group Study

MYC Copy Number Aberrancies Predict a Worse Prognosis in Patients with Diffuse Large B-Cell Lymphoma

Experience with MRD Testing in B- ALL By Flow Cytometry Does Not Prevent Interpretative Discordance

MYC/BCL2 Double Hit Lymphoma: What Really Matters

Mutational Burden in Acute Myeloid Leukemia Is Largely Age Dependent

Evidence-Based, Patient-Specific Guidelines Provide Efficient and Cost-Effective Molecular and Cytogenetic Testing in Hematologic Malignancy

HIV-Associated Plasmablastic Lymphoma: A Multi-Institutional Study

Increased Sensitivity of Prothrombin Time Using Recombinant Tissue Thromboplastin Reagents: Implications for Plasma Transfusion.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only